Founded in 2017 in Trieste, InSilicoTrials offers a double-sided, cloud-based platform for modeling and simulation to help pharma and medical devices companies reducing time and cost for R&D and regulatory processes.
The company operates in the field of in silico technology, a term used to refer to clinical trials through computer simulations. Through the development of artificial models, researchers are able to assess the safety, efficacy, and risks of biomedical devices and pharmacological treatments with a view to their commercialization. Thanks to its pay-per-use model, InSilicoTrials makes the simulation world available not only to a few market leaders but to all the more than 52,000 medical companies and 3,200 pharmaceutical companies operating in the market.
We are happy to announce our Series A in InSilicoTrials, a cloud-based platform for modeling & simulation that helps pharma and medical device companies to reduce time and cost for R&D and regulatory processes up to 60%. In silico technology — the adoption of...